Role of Simvastatin in Relapsing-Remitting Multiple Sclerosis

Clinical trial NCT04178980 · UNKNOWN

Trial details

NCT number: NCT04178980
Sponsor: Assiut University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Simvastatin Multiple Sclerosis

Start date: 2020-01-01
Primary completion: 2022-01-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.